Protein Assays Market Forecast Analysis Through 2030 With Insights On Industry Expansion

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Growth In Market Value Is Anticipated For The Protein Assays Market Between 2026 And 2030?

The protein assays market has experienced substantial expansion in its size over recent years. This market is anticipated to expand from $3.28 billion in 2025 to $3.77 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.9%. Key drivers for its historical growth include the broadening of biomedical research activities, the heightened application of proteins in drug development, the increased uptake of laboratory automation, the rise in clinical diagnostics testing, and the presence of standardized protein reagents.

The protein assays market size is expected to experience rapid growth in the upcoming years. It is projected to expand to $6.51 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 14.6%. The expansion foreseen during this period can be attributed to an increasing focus on personalized medicine research, a rising demand for advanced proteomics tools, the broadening of pharmaceutical R&D pipelines, the growing adoption of automated laboratory workflows, and increasing investments in life sciences research infrastructure. Noteworthy trends for the forecast period include the increasing adoption of high-sensitivity assay kits, the rising use of automated protein quantification instruments, a growing demand for multiplex protein analysis, the expansion of high-throughput screening applications, and an enhanced focus on assay accuracy and reproducibility.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9173&type=smp

Which Growth Factors Are Strengthening The Protein Assays Market Landscape?

The expansion of pharmaceutical industries is projected to propel the protein assay market in the coming years. This industry specializes in the research, development, production, and distribution of medicines for disease prevention, diagnosis, and treatment. Its expansion stems from various elements, including increasing global health requirements, elevated healthcare expenditures, and the rising need for preventive care. Within the pharmaceutical sector, protein assays are indispensable, as they facilitate precise measurement of protein concentration and activity, crucial for drug discovery, development, and quality assurance. A notable example is the data from June 2023, where the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing the pharmaceutical industry in Europe, reported that total pharmaceutical production in Europe reached €390,000 million ($422,803 million) in 2023, an increase from €363,300 million ($393,857 million) in 2022. Consequently, the growth observed in the pharmaceutical industry serves as a primary driver for the advancement of the protein assay market.

How Are Different Segment Groups Identified Within The Protein Assays Market?

The protein assays market covered in this report is segmented –

1) By Product Type: Reagents And Kits, Instruments

2) By Technology Type: Absorbance Based Protein Assays, Colorimetric Protein Assays, Fluorescence Based Protein Assays

3) By End User: Pharmaceutical Industry, Biotechnology Industry, Clinical Laboratories, Hospitals, Academic Research Institutes

Subsegments:

1) By Reagents And Kits: Colorimetric Assay Kits, Fluorescent Assay Kits, Luminescent Assay Kits, Other Assay Kits

2) By Instruments: Spectrophotometers, Microplate Readers, Other Analytical Instruments

Which Trends Are Affecting The Protein Assays Market Framework?

Major companies operating within the prostate-specific membrane antigen (PSMA) theranostic kits market are prioritizing the development of innovative solutions, such as PSMA-targeted radioligand kits, to address the escalating demand for precision oncology, focused prostate cancer diagnosis, and therapeutic interventions. PSMA-targeted radioligand kits are medical products that integrate a ligand specifically engineered to bind to Prostate-Specific Membrane Antigen (PSMA) with a radioactive isotope for either diagnostic imaging or targeted therapy of prostate cancer. As an illustration, in March 2025, Telix Pharmaceuticals Limited, an Australia-based radiopharmaceutical company, launched Illuccix, an advanced kit designed for the preparation of Gallium-68 gozetotide injection. This kit allows hospitals and nuclear medicine facilities to label the radionuclide immediately before injection for PET imaging of PSMA-positive prostate cancer lesions. The kit’s notable characteristics encompass a ready-to-use preparation method, disease-specific targeting, fast imaging capability, and compatibility with theranostic workflows, which facilitates improved detection of metastatic lesions, more effective treatment planning, and better monitoring of therapy response. Its uses include diagnosing recurrent or metastatic prostate cancer and informing personalized treatment choices, representing a significant progression beyond conventional imaging or non-targeted therapies.

Who Are The Businesses Driving Activity In The Protein Assays Market?

Major companies operating in the protein assays market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Roche Diagnostics International AG, Danaher Corporation, Merck KGaA, Siemens Healthineers AG, R And D Systems Inc, Lonza Group AG, PerkinElmer Inc, Bio Rad Laboratories Inc, Takara Bio Inc, Qiagen NV, Promega Corporation, Abcam plc, BioVision Inc, Cayman Chemical Company, Enzo Life Sciences Inc, Novus Biologicals LLC, Abnova Corporation, Elabscience Biotechnology Co Ltd, Geno Technology Inc, Cytoskeleton Inc

Access The Complete Protein Assays Market Report:

https://www.thebusinessresearchcompany.com/report/protein-assays-global-market-report

Which Region Accounts For The Highest Share Of The Protein Assays Market?

North America was the largest region in the protein assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global protein assays market report during the forecast period. The regions covered in the protein assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Protein Assays Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=9173&type=smp

Browse Through More Reports Similar to the Global Protein Assays Market 2026, By The Business Research Company

Prostate Cancer Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/prostate-cancer-diagnostics-global-market-report

Prostate Cancer Nuclear Medicine Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/prostate-cancer-nuclear-medicine-diagnostics-global-market-report

Prostate Cancer Drugs Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/prostate-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795